Stefanie Hennig

20 Cornwall Street
Brisbane, QLD, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy.

Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy.

Journal: Blood cancer journal

Published: June 03, 2025

Impact of using time-averaged exposure metrics on binary endpoints in exposure-response analyses.

Impact of using time-averaged exposure metrics on binary endpoints in exposure-response analyses.

Journal: Frontiers in pharmacology

Published: August 27, 2024

Examining Different Methods to Assess Busulfan Exposure in Pediatric Hematopoietic Stem Cell Transplant Recipients.

Examining Different Methods to Assess Busulfan Exposure in Pediatric Hematopoietic Stem Cell Transplant Recipients.

Journal: Therapeutic drug monitoring

Published: August 15, 2024

Pharmacokinetics of Edoxaban 15 mg in Very Elderly Patients with Nonvalvular Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Study.

Pharmacokinetics of Edoxaban 15 mg in Very Elderly Patients with Nonvalvular Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Study.

Journal: Thrombosis and haemostasis

Published: April 19, 2024

Role of pharmacometrics and systems pharmacology in facilitating efficient dose optimization in oncology.

Role of pharmacometrics and systems pharmacology in facilitating efficient dose optimization in oncology.

Journal: CPT: pharmacometrics & systems pharmacology

Published: October 11, 2023

A physiological approach to renal clearance: From premature neonates to adults.

A physiological approach to renal clearance: From premature neonates to adults.

Journal: British journal of clinical pharmacology

Published: September 29, 2023

SuPreme Study: a protocol to study the neuroprotective potential of sulfate among very/extremely preterm infants.

SuPreme Study: a protocol to study the neuroprotective potential of sulfate among very/extremely preterm infants.

Journal: BMJ open

Published: July 14, 2023

Specific T-cell receptor beta-rearrangements of gluten-triggered CD8+ T-cells are enriched in celiac disease patients' duodenal mucosa.

Specific T-cell receptor beta-rearrangements of gluten-triggered CD8+ T-cells are enriched in celiac disease patients' duodenal mucosa.

Journal: Clinical immunology (Orlando, Fla.)

Published: July 13, 2023

Trastuzumab Deruxtecan Dosing in Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer: Population Pharmacokinetic Modeling and Exposure-Response Analysis.

Trastuzumab Deruxtecan Dosing in Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer: Population Pharmacokinetic Modeling and Exposure-Response Analysis.

Journal: Journal of clinical pharmacology

Published: February 02, 2023

Barriers to global pharmacometrics: educational challenges and opportunities across the globe.

Barriers to global pharmacometrics: educational challenges and opportunities across the globe.

Journal: CPT: pharmacometrics & systems pharmacology

Published: September 27, 2022

Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools.

Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools.

Journal: Antibiotics (Basel, Switzerland)

Published: April 25, 2022

Population pharmacokinetic model for once-daily intravenous busulfan in pediatric subjects describing time-associated clearance.

Population pharmacokinetic model for once-daily intravenous busulfan in pediatric subjects describing time-associated clearance.

Journal: CPT: pharmacometrics & systems pharmacology

Published: November 17, 2021

Showing 1-12 of 72

Last Updated: 09/26/2026